NICE recommends new treatment option for people with common heart condition

NICE has today (23 May) published final guidance recommending rivaroxaban (Xarelto, Bayer HealthCare) as an option for the prevention of stroke and systemic embolism in people with atrial fibrillation. Atrial fibrillation (AF) occurs when the

Published May 2012

NICE recommends new treatment option for people with common heart condition

In final guidance published today (27 February) NICE has recommended apixaban (Eliquis, Bristol-Myers Squibb and Pfizer), in accordance with its licensed indications, as an option for the prevention of stroke and systemic embolism in some people

Published February 2013

NICE recommends new treatment option for people with common heart condition

Following the receipt of further evidence from Bayer HealthCare of the clinical and cost effectiveness of its drug rivaroxaban (Xarelto), NICE has published final draft guidance recommending rivaroxaban as an option for the prevention of stroke and

Published March 2012

NICE recommends new treatment option for multiple sclerosis

In final draft guidance the National Institute for Health and Care Excellence (NICE) has recommended the use of Genzyme´s multiple sclerosis drug teriflunomide (also called Aubagio). NICE is appraising teriflunomide as a treatment for adults

Published December 2013

NICE recommends first pill treatment for some people with MS

In its final guidance, out today (25 April), NICE, the healthcare guidance body recommends that the NHS provides fingolimod (Gilenya, Novartis) - the first pill-based medicine to help reduce the number of relapses - for some adults who have highly

Published April 2012

NICE recommends new treatment option for patients with multiple sclerosis

Alemtuzumab has been described by experts as a “revolutionary” treatment for some people which could allow them to live their lives as they had before being diagnosed with relapsing-remitting MS. NICE has appraised alemtuzumab as a

Published June 2014

NICE recommends new drug to treat blood clots

In final draft guidance published today (1 June), NICE has recommended rivaroxaban (Xarelto, Bayer Healthcare) as an option for treating deep vein thrombosis and preventing recurrent deep vein thrombosis and pulmonary embolism in adults diagnosed

Published June 2012

NICE recommends new drug for adults with cystic fibrosis in final draft guidance

In final draft recommendations published today (26 October), NICE has recommended mannitol dry powder (Bronchitol, Pharmaxis) as an option for treating cystic fibrosis in some adults. The draft guidance, which is now with consultees who have the

Published October 2012

NICE recommends new drug to treat blood clots

In final guidance published today (25 July), NICE has recommended rivaroxaban (Xarelto, Bayer Healthcare) as an option for treating deep vein thrombosis and preventing recurrent deep vein thrombosis and pulmonary embolism in adults diagnosed with

Published July 2012

NICE recommends new drug for adults with cystic fibrosis

NICE, the healthcare guidance body, has issued new guidance recommending mannitol dry powder (Bronchitol, Pharmaxis) as an option for treating cystic fibrosis in some adults. Cystic fibrosis affects the internal organs, especially the lungs and

Published November 2012

NICE recommends new cervical cancer diagnostic test

Final guidance published today by healthcare guidance body NICE supports the use of a new colposcopy technology, DySIS (DySIS Medical), as a cost-effective option for examining the uterine cervix in women referred for colposcopy and recommends that

Published August 2012

NICE recommends drug for idiopathic pulmonary fibrosis in latest draft guidance

In draft guidance out today (Thursday 21 March), the National Institute for Health and Clinical Excellence (NICE) states its intention to recommend pirfenidone (also known as Esbriet and manufactured by InterMune) as a treatment option for certain

Published March 2013

NICE recommends drug for idiopathic pulmonary fibrosis in final guidance

The National Institute for Health and Care Excellence (NICE) has published final guidance for the NHS, which recommends pirfenidone (marketed as Esbriet and manufactured by InterMune) for certain people who have the chronic lung condition,

Published April 2013

NICE recommends depth of anaesthesia monitors

Healthcare guidance body NICE has today (21 November) published final guidance recommending the use of the Bispectral Index (BIS, Covidien), E-Entropy (GE Healthcare) and Narcotrend-Compact M (MT MonitorTechnik GmbH & Co) EEG-based depth of

Published November 2012

NICE recommends dedicated NHS service for women with a suspected miscarriage or ectopic pregnancy

The NHS should consider setting up dedicated services for pregnant women who may have an ectopic pregnancy[1] or who experience pain or bleeding in their first trimester (before 13 weeks gestation). This is according to a new guideline published

Published December 2012

NICE recommends Botox for preventing headaches in adults who have chronic migraine

The National Institute for Health and Care Excellence (NICE) has published final guidance today (Wednesday 27 June), which recommends Botox injections to prevent headaches in some adults who experience chronic migraine. NICE recommends Botox (known

Published June 2012

NICE recommends bortezomib for newly diagnosed blood cancer, multiple myeloma

Multiple myeloma develops from cells in the bone marrow. Almost 4,000 cases are diagnosed every year in the UK. There is currently no cure; there are only treatments to stop its progress and relieve symptoms. NICE's independent experts examined the

Published April 2014

NICE recommends another new treatment for lung cancer

 NICE has given the go ahead for afatinib (also known as Giotrif and made by Boehringer Ingelheim) to be paid for by the NHS. Afatinib is a targeted treatment for non-small-cell lung cancer known as an EGFR-TK inhibitor. It works by

Published April 2014

NICE recommends acute sickle cell episodes to be treated as medical emergencies in new guideline

In a new guideline published today (Wednesday 27 June), NICE, the healthcare guidance body, has recommended that acute painful sickle cell episodes should be treated as acute medical emergencies, and analgesia offered to all patients within 30

Published June 2012

NICE recommends abiraterone and erlotinib

In final guidance published today, NICE, the healthcare guidance body, is pleased to be able to recommend two new treatment options for prostate cancer and for lung cancer. Abiraterone (Zytiga, Janssen) is recommended in combination with prednisone

Published June 2012

NICE-recommended clinical trial due to start on promising wound healing device

The first clinical trial resulting from NICE medical technology guidance recommendations is due to start soon on a device to promote wound healing. NICE issued guidance in 2011 strongly encouraging further research on the use of the MIST Therapy

Published August 2012

NICE publish new quality standards on colorectal cancer and stable angina

NICE has today (13 August) published new quality standards on colorectal cancer (commonly known as colon cancer, rectal cancer or bowel cancer) and stable angina. Colorectal cancer is the third most common type of cancer in England. Around 83% of

Published August 2012

NICE publishes updated recommendations on implantable devices for the treatment of life-threatening arrhythmias and heart failure

In final guidance NICE has clearly defined which heart devices – known as implantable cardiac devices – are the most clinically and cost effective. The new guidance will help people with a variety of heart conditions including those with

Published June 2014

NICE publishes positive final guidance on device for use during electrosurgery

The National Institute for Health and Care Excellence today (22 August) publishes final guidance on a new medical technology device designed to be used during surgery. The guidance advises that the use of the Mega Soft Patient Return Electrode could

Published August 2012

NICE publishes new standards to improve care for children and young people with cancer

All children and young people with cancer should have the opportunity to take part in relevant clinical trials to increase knowledge about the disease and improve survival rates. This is one of a number of recommendations by the National Institute

Published February 2014

NICE publishes new quality standards for lung cancer and hip fracture

NICE has today (30 March) published new quality standards on lung cancer and hip fracture. Each year sees more than 40,000 new cases of lung cancer diagnosed in the UK, and there are 35,000 deaths from the disease each year, more than breast cancer

Published March 2012

NICE publishes new quality standard for bacterial meningitis and meningococcal septicaemia in children and young people

NICE has today (29 June) published a new quality standard for bacterial meningitis and meningococcal septicaemia in children and young people. Bacterial meningitis occurs when bacteria found normally in the upper respiratory tract infect the lining

Published June 2012

NICE publishes new ovarian cancer quality standard

NICE has today (23 May) published a new quality standard for ovarian cancer, which states that an integrated approach to the diagnosis and management of the disease is fundamental to the delivery of high quality care to women. Every year in the UK,

Published May 2012

NICE publishes new measures to review the benefits to patients from services commissioned by Clinical Commissioning Groups

NICE, the health and social care guidance body, has today (Thursday 1 August) published 15 proposed new indicators to support better quality healthcare being commissioned by Clinical Commissioning Groups - the local NHS bodies, led by clinicians,

Published August 2013

NICE publishes new guideline on the management of acute upper gastrointestinal bleeding

NICE, the healthcare guidance body, has today (Wednesday 13 June) published a new guideline on the management of acute upper gastrointestinal (GI) bleeding. Bleeding in the oesophagus, stomach or duodenum is the most common emergency managed by

Published June 2012

NICE publishes new guideline on Crohn's disease

NICE has today (Wednesday 10 October) published guidance on the role of new and established treatments for the management of Crohn´s disease in adults and children. Crohn's disease is a chronic inflammatory condition that mainly affects the

Published October 2012

NICE publishes new draft guidance on ranibizumab for diabetic macular oedema after rapid review

In new draft guidance issued today (5 October) for consultation, NICE, the healthcare guidance body, has recommended ranibizumab (Lucentis, Novartis) as an option for treating visual impairment caused by diabetic macular oedema (DMO). NICE conducted

Published October 2012

NICE publishes guideline on rehabilitation for people who have had a stroke

NICE has published guidance aimed at improving outcomes for people who have a disability caused by a stroke. Thanks to improvements in stroke care, each year most of the 125,000 people in England, Wales and Northern Ireland who have a stroke survive

Published June 2013

NICE publishes guideline on managing medicines in care homes

NICE, the health and social care guidance body, has published its guideline for those involved in handling, prescribing, commissioning and other decision-making about medicines in care homes. The guideline makes recommendations about the systems and

Published March 2014

NICE publishes guideline on assessing risk of fragility fracture in adults

The National Institute for Health and Care Excellence (NICE) today (8 August) publishes final guidance on assessing the risk of fragility fracture in adults. The short clinical guideline advises on methods to help clinicians assess who might be at

Published August 2012

NICE publishes guideline for treating people with acute heart attack

A new NICE guideline aims to improve the outcomes for people who have suffered the most severe type of heart attack. If you've had or are having a heart attack, time is of the essence. Professor Huon Gray, Consultant Cardiologist and National

Published July 2013

NICE publishes guidance on tests used during surgery to detect whether breast cancer has spread

The National Institute for Health and Care Excellence has recommended a new test for surgeons to use during operations to discover if breast cancer has spread. The test - the RD-100i OSNA system produced by Sysmex UK - is used while surgery to

Published August 2013

NICE publishes guidance for ultrasound testing to diagnose liver cancer

Guidance published today (29 August) by NICE supports the use of contrast-enhanced ultrasound with SonoVue (Bracco UK) to diagnose liver cancer. The guidance recommends the use of SonoVue in adults to investigate damage (lesions) to the liver that

Published August 2012

NICE publishes first menu of COF indicators

NICE has today (Wednesday 1 August) published the first menu of 44 new proposed indicators recommended by the Commissioning Outcomes Framework (COF) Advisory Committee. Covering domains including preventing people from dying prematurely, and

Published August 2012

NICE publishes first Evidence summary: unlicensed or off-label medicine

Tranexamic acid (Cyklokapron, Pfizer) for significant haemorrhage (severe bleeding) following trauma is the first topic to be covered by NICE as part of its new service to provide high quality information to the NHS and patients in England about the

Published October 2012
Get involved